|
|
|
Volumn 23, Issue 8, 2012, Pages 471-
|
|
High patient compliance with nicacin/laropiprant in large clinical trial: Interim safety and tolerability results from HPS-2 THRIVE study released at 2012 ESC congress
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
APOLIPOPROTEIN A;
APOLIPOPROTEIN B;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
LAROPIPRANT PLUS NICOTINIC ACID;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
PLACEBO;
DIABETES MELLITUS;
DRUG SAFETY;
DRUG TOLERABILITY;
HEART PROTECTION;
HUMAN;
MYOPATHY;
PATIENT COMPLIANCE;
RACE DIFFERENCE;
SHORT SURVEY;
CHEMICAL SAFETY;
CHINA;
CHOLESTEROL, HDL;
CORONARY ARTERY DISEASE;
EUROPE;
FOLLOW-UP STUDIES;
HUMANS;
INDOLES;
LIPID METABOLISM;
MUSCULAR DISEASES;
NIACIN;
PATIENT COMPLIANCE;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
|
|
EID: 84875236535
PISSN: 19951892
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (1)
|
|
References (0)
|